Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson
Queensland Health
Express Scripts

Generated: January 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 050689

« Back to Dashboard

NDA 050689 describes MYCOBUTIN, which is a drug marketed by Pharmacia And Upjohn and is included in one NDA. It is available from four suppliers. Additional details are available on the MYCOBUTIN profile page.

The generic ingredient in MYCOBUTIN is rifabutin. There are three drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the rifabutin profile page.
Summary for 050689
Applicant:Pharmacia And Upjohn
Therapeutic Class:Antimycobacterials
Formulation / Manufacturing:see details
Pharmacology for NDA: 050689
Medical Subject Heading (MeSH) Categories for 050689
Suppliers and Packaging for NDA: 050689
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
MYCOBUTIN rifabutin CAPSULE;ORAL 050689 NDA Pharmacia and Upjohn Company LLC 0013-5301 0013-5301-17 100 CAPSULE in 1 BOTTLE (0013-5301-17)
MYCOBUTIN rifabutin CAPSULE;ORAL 050689 NDA Physicians Total Care, Inc. 54868-2841 54868-2841-0 50 CAPSULE in 1 BOTTLE, PLASTIC (54868-2841-0)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength150MG
Approval Date:Dec 23, 1992TE:ABRLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.